Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA3 | P07451 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9300608 | 0.88 | ALDH1A1 (0.45) | ALDH1A1MAPTKMT2AHCAR2THRB | |
| SCHEMBL6293590 | 0.83 | ALDH1A1 (0.40) | ALDH1A1MAPTKMT2ALMNANPSR1 | |
| SCHEMBL28733839 | 0.82 | ALDH1A1 (0.42) | ALDH1A1MAPTKMT2ATHRBLMNA | |
| SCHEMBL440528 | 0.82 | ALDH1A1 (0.50) | ALDH1A1MAPTKMT2ALMNATAS1R3 | |
| Styrene SCHEMBL9350396 | 0.81 | ALDH1A1 (0.52) | ALDH1A1MAPTKMT2AHCAR2LMNA | |
| Styrene SCHEMBL9142044 | 0.81 | ALDH1A1 (0.52) | ALDH1A1MAPTKMT2AHCAR2LMNA | |
| SCHEMBL27590291 | 0.81 | MAPT (0.58) | ALDH1A1MAPTKMT2AHCAR2THRB | |
| SCHEMBL3235668 | 0.80 | HCAR2 (0.50) | ALDH1A1MAPTKMT2AHCAR2LMNA | |
| SCHEMBL15563736 | 0.80 | HCAR2 (0.50) | ALDH1A1MAPTKMT2AHCAR2LMNA | |
| Hydrochloric Acid SCHEMBL9497409 | 0.79 | HCAR2 (0.49) | ALDH1A1MAPTKMT2AHCAR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1973587-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | Allaccem, Inc. (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007070801-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM, INC. (US) | 2007-06-21 | — | — | WO | claimed |
| US-6326417-B1 | CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES | JENERIC/PENTRON INCORPORATED | 2001-12-04 | — | — | US | claimed |
| EP-1973587-B1 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM INC (US) | 2019-02-06 | — | — | EP | disclosed |
| US-9994444-B2 | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | ALLACCEM, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-9957395-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2018-05-01 | — | — | US | disclosed |
| US-9212286-B2 | Methods and systems for coating a surface | ALLACCEM, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| EP-2125026-B1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM INC (US) | 2014-09-24 | — | — | EP | disclosed |
| US-20130150809-A1 | METHODS AND SYSTEMS FOR COATING A MEDICAL DEVICE | ALLACCEM, INC. | 2013-06-13 | — | — | US | disclosed |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. (US) | 2013-02-14 | — | — | US | disclosed |
| US-8268381-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INC. | 2008-11-06 | — | — | US | disclosed |
| EP-1973587-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | Allaccem, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2008103847-A2 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | ALLACCEM, INCORPORATED (US) | 2008-08-28 | — | — | WO | disclosed |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | ALLACCEM, INC. | 2008-08-28 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| WO-2007070801-A2 | METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS | ALLACCEM, INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| US-6326417-B1 | CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES | JENERIC/PENTRON INCORPORATED | 2001-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | DNMT1, TET2, POLR1C | ALDH1A1 2775/4885MAPT 4603/4885KMT2A 1094/4885 |
| US-20130040924-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | ALDH1A1 1058/4885MAPT 1400/4885KMT2A 2822/4885 |
| US-20080207581-A1 | Applying to a surface one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning | DNMT1, TET2, CD14 | ALDH1A1 2261/4885MAPT 4796/4885KMT2A 1123/4885 |
| US-20080275141-A1 | BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE | PKD1, VHL, PKD2 | ALDH1A1 1058/4885MAPT 1400/4885KMT2A 2822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.